Veracyte (VCYT) Share-based Compensation (2012 - 2026)

Veracyte has reported Share-based Compensation for 15 years, with the latest figure at $14.1 million in Q2 2026.

• Share-based Compensation for Q2 2026 came in at $14.1 million, up 28.23% year-over-year; the trailing twelve-month figure through Jun 2026 was $48.5 million (up 20.3% YoY), and the FY2025 annual result was $43.6 million, up 20.28% from the prior year.
• Share-based Compensation rose to $14.1 million in Q2 2026, from $12.8 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $14.1 million in Q2 2026 and troughed at $5.9 million in Q2 2022.
• A 5-year average of $9.3 million and a median of $9.2 million in 2024 frame the typical range for Share-based Compensation.
• The largest YoY upside for Share-based Compensation was 418.69% in 2022 against a maximum downside of 94.77% in 2022.
• A 5-year view of Share-based Compensation shows it stood at $6.9 million in 2022, then gained by 9.39% to $7.5 million in 2023, then rose by 28.18% to $9.6 million in 2024, then grew by 13.21% to $10.9 million in 2025, then grew by 29.22% to $14.1 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $14.1 million in Q2 2026, $12.8 million in Q1 2026, and $10.9 million in Q4 2025.